Solid Biosciences (NASDAQ:SLDB) reported quarterly losses of $(0.17) per share. This is a 56.41 percent increase over losses of $(0.39) per share from the same period last year.
New Street Research Downgrades ASML Holding to Neutral
New Street Research analyst Pierre Ferragu downgrades ASML Holding (NASDAQ:ASML) from Buy to Neutral.